More than two-thirds of cancer patients in the U.S. receiving chemotherapy develop anemia, a low red blood cell count. More than half of chemotherapy patients report that fatigue, a common symptom of anemia, affects their daily lives more than any other side effect of treatment, including nausea, pain and depression.
Anemia treatments have been available for more than a decade, and treatment typically takes more than two hours per visit. Now, the FDA has approved every-three-week dosing of Aranesp, a medication that increases red blood cell counts, for the treatment of chemotherapy-induced anemia. This extended dosing can provide added convenience for patients and less injection-related burden for patients and health care professionals. Aranesp is the only anemia treatment approved for this less frequent dosing.More than two-thirds of cancer patients in the U.S. receiving chemotherapy develop anemia, a low red blood cell count. More than half of che...all »More than two-thirds of cancer patients in the U.S. receiving chemotherapy develop anemia, a low red blood cell count. More than half of chemotherapy patients report that fatigue, a common symptom of anemia, affects their daily lives more than any other side effect of treatment, including nausea, pain and depression.
Anemia treatments have been available for more than a decade, and treatment typically takes more than two hours per visit. Now, the FDA has approved every-three-week dosing of Aranesp, a medication that increases red blood cell counts, for the treatment of chemotherapy-induced anemia. This extended dosing can provide added convenience for patients and less injection-related burden for patients and health care professionals. Aranesp is the only anemia treatment approved for this less frequent dosing.«
Download is starting. Save file to your computer. If the download does not start automatically, right-click this link and choose "Save As". How to get videos onto the iPod or PSP.
